# InnoPharmaScreen

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/innopharmascreen

- Industry: Pharmaceuticals
- Headquarters: South Korea
- Website: www.innopharmascreen.com
- Total disclosed funding: $1.8M
- Latest round: Series A (Dec 10, 2020)
- Investors on record: 3

## About

Founded in 2009 and based in Incheon, South Korea, InnoPharmaScreen Inc. operates as a developer of a protein chip-based and AI-aided drug discovery platform. As of 2020, it completed two rounds of financing.

The company has developed new drug candidates through the new drug development platform and is conducting clinical trials on reserved pipelines such as asthma therapeutics and non-small cell lung cancer therapeutics. At present, it has 2 clinical and 3 nonclinical pipelines.

## Funding rounds

- Series A, Dec 10, 2020, $1.8M — KDB Capital, Capstone Partners, Magna Investment

## Investors

- KDB Capital (https://capitalatlas.ai/funds/kdb-capital) — Series A
- Capstone Partners (https://capitalatlas.ai/funds/capstone-partners) — Series A
- Magna Investment (https://capitalatlas.ai/funds/magna-investment) — Series A